The ability of NAC to cross the blood brain barrier has been questioned, an important consideration for use in neurodegenerative diseases
In both mice and rhesus macaques, a two-dose intramuscular immunization regimen resulted in durable, robust, and broad neutralization against all SARS-CoV-2 variants tested, including the Omicron subvariants BA.4/539 and BQ.140
A controlled trial published in Human Physiology (Dolotov et al., 2006) showed that intranasal Semax at 200 mcg twice daily increased BDNF expression in the basal forebrain by approximately 70% over a seven-day period in patients with ischemic stroke
BPC-157 has also shown positive effects in the treatment of gastrointestinal diseases such as Crohns disease and ulcerative colitis
doi: 10.1016/j.ceb.2017.03.010 82 TakahashiYHeHTangZHattoriTLiuYYoungMMet al
Asia-Pacific Clinical Trials Market Trends The Asia-Pacific region is expected to exhibit the fastest CAGR during the forecast period, fueled by a burgeoning healthcare sector, increased investments in clinical research, and a growing patient population
